Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Antidiabetics Oral
Item
treatment with oads (oral anti-diabetic drugs) for more than 6 months
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
Metformin
Item
ongoing stable treatment with metformin for at least 2 months
boolean
C0025598 (UMLS CUI [1])
Pills Insulin Releasing | Dose Stable
Item
ongoing stable treatment with minimum half maximal dose of any insulin secretagogue for at least 2 months
boolean
C0994475 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
C1283071 (UMLS CUI [1,3])
C0178602 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
Insulin naive
Item
insulin naive
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Glycosylated hemoglobin A
Item
hba1c (glycosylated haemoglobin a1c) between 7.0% and 11.0% (inclusive of both values)
boolean
C0019018 (UMLS CUI [1])
Medical contraindication Metformin
Item
metformin contraindication according to local practice
boolean
C1301624 (UMLS CUI [1,1])
C0025598 (UMLS CUI [1,2])
Thiazolidinediones
Item
tzd (thiazolidinedione) treatment for the last 5 months before trial start
boolean
C1257987 (UMLS CUI [1])
Systemic Corticosteroid Therapy
Item
systemic treatment with any corticosteroid 3 months before trial start
boolean
C4053960 (UMLS CUI [1])
Disease Interferes with Clinical Trial | Condition Interferes with Clinical Trial
Item
any disease or condition which according to the investigator would interfere with the trial
boolean
C0012634 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])